Society of Actuaries Research Brief Impact of COVID-19 June 12, 2020

Total Page:16

File Type:pdf, Size:1020Kb

Society of Actuaries Research Brief Impact of COVID-19 June 12, 2020 Society of Actuaries Research Brief Impact of COVID-19 June 12, 2020 June 2020 2 Society of Actuaries Research Brief Impact of COVID-19 June 12, 2020 AUTHORS R. Dale Hall, FSA, MAAA, CERA, CFA Cynthia S. MacDonald, FSA, MAAA Peter J. Miller, ASA, MAAA Achilles N. Natsis, FSA, MAAA Lisa A. Schilling, FSA, EA, FCA, MAAA Steven C. Siegel, ASA, MAAA J. Patrick Wiese, ASA REVIEWERS Michael C. Dubin, FSA, FCAS, FCA, MAAA Timothy J. Geddes, FSA, EA, FCA, MAAA Umesh Haran, FSA, ACIA, CERA Jing Lang, FSA, FCIA Ronald Poon Affat, FSA, FIA, MAAA, CFA Max J. Rudolph, FSA, MAAA, CERA, CFA Nazir Valani, FSA, FCIA, MAAA Greger Vigen Caveat and Disclaimer This study is published by the Society of Actuaries (SOA) and contains information from a variety of sources. The study is for informational purposes only and should not be construed as professional or financial advice. The SOA does not recommend or endorse any use of the information provided in this study. The SOA makes no warranty, express or implied, or representation whatsoever and assumes no liability in connection with the use or misuse of this study. Copyright © 2020 by the Society of Actuaries. All rights reserved. Copyright © 2020 Society of Actuaries 3 CONTENTS Introduction.............................................................................................................................................................. 5 Key Statistics............................................................................................................................................................. 6 Reported Cases .............................................................................................................................................................. 6 Worldwide Cases ............................................................................................................................................... 6 U.S. and Canadian cases .................................................................................................................................... 8 U.S. Subpopulations ........................................................................................................................................ 10 Case Fatality Rates ....................................................................................................................................................... 11 CFRs by Age Group .......................................................................................................................................... 12 U.S. Subpopulations ........................................................................................................................................ 14 CFR Limitations ................................................................................................................................................ 15 Reported Cases vs. Actual Cases..................................................................................................................... 19 COVID-19 Mortality Rate Curves ................................................................................................................................. 19 COVID-19 Mortality Versus Other Causes of Death ................................................................................................... 22 Comorbidities in COVID-19 Deaths ............................................................................................................................. 23 COVID-19 Mortality Relative to All Causes of Death .................................................................................................. 24 Excess Mortality ........................................................................................................................................................... 25 COVID-19 Deaths in Senior Care Facilities .................................................................................................................. 26 Comparison to Past Pandemics and Influenza ........................................................................................................... 28 COVID-19 and Past Epidemics and Pandemics .............................................................................................. 28 COVID-19 and Influenza .................................................................................................................................. 28 Mortality by Socioeconomic status ............................................................................................................................. 30 Health Care Cost and Utilization ................................................................................................................................. 31 Supply of Medical Resources .......................................................................................................................... 32 Hospitalization Rates ....................................................................................................................................... 32 Comorbidities .................................................................................................................................................. 38 COVID-19 Treatment ....................................................................................................................................... 39 Non-COVID-19 Health care ............................................................................................................................. 40 Mental Health .................................................................................................................................................. 41 Infection Spread Rate .................................................................................................................................................. 41 Economic and Asset Impact .................................................................................................................................... 44 Macroeconomic Variables ........................................................................................................................................... 44 Monetary and Fiscal Policy ............................................................................................................................. 44 Employment..................................................................................................................................................... 46 Gross Domestic Product .................................................................................................................................. 47 Asset Values and Volatility........................................................................................................................................... 49 Low Interest Rate Environment .................................................................................................................................. 50 Reinvestment and Default Risk ................................................................................................................................... 51 Impact on Insurance Industry .................................................................................................................................. 54 Impact on Life Insurance Companies .......................................................................................................................... 54 Impact on Health Insurance Companies ..................................................................................................................... 55 Impact on Property/Casualty Coverages .................................................................................................................... 57 Business Interruption Insurance ..................................................................................................................... 57 Cancellation Insurance .................................................................................................................................... 58 Workers’ compensation .................................................................................................................................. 58 Personal Automobile Insurance ...................................................................................................................... 59 Medical Malpractice Insurance ...................................................................................................................... 60 Financial Guaranty/Mortgage Guaranty ........................................................................................................ 60 Impact on Captive Insurance Companies ................................................................................................................... 60 Copyright © 2020 Society of Actuaries 4 Changes in Insurance Regulation and Contractual Requirements ............................................................................ 60 Cyber Risk ..................................................................................................................................................................... 61 Impact on Retirement Plans .................................................................................................................................... 62 Corporate Defined Benefit Retirement Plans ............................................................................................................
Recommended publications
  • Actuaries Abroad
    Actuaries Abroad California Actuarial Student Summit 2019 UC Santa Barbara Andrew Peterson, FSA, EA, MAAA Senior Director, International, SOA May 25, 2019 Discussion topics ▪ Global actuarial profession ▪ Becoming an actuary & SOA pathway ▪ Working internationally: qualifications & job market 2 Around the Globe – Snapshot Global Actuarial Profession (Total ~80,000) 2% 0% 3% 4% North America 8% Europe Asia 44% Oceania Latin America Africa 38% Middle East Estimated results based on 2018 Intl. Actuarial Association (IAA) data; distributions are approximate due to potential overlap in membership in different regions. 3 Around the Globe – Snapshot SOA Global Footprint (2018) SOA Members + Candidates in Asia (2018) 2% 1% 1% 1,261 22 China 4% Hong Kong 4% 1,221 3,048 United States Malaysia 5% 30% Canada Korea, Republic of China Taiwan 11% 5,213 Asia-Pacific Thailand 20,560 Singapore Latin America 11% Philippines Rest of the World 20% Vietnam 11% Japan Members : 31,325 Indonesia CAS Global Footprint (2018) IFoA Global Footprint (2017/18) 135 186 79 105 UK 538 4,765 US 903 India 559 Canada Ireland 1185 Bermuda South Africa 1636 China/HK/Singapore China 16253 6,944 UK/Switzerland ROW ROW 6064 Members : 8,352 Includes both Actuaries (~15,000) + Students (~16,000) = ~31,000 4 Becoming an actuary & SOA pathway Becoming an Actuary – 4 Primary Intl. Credentials SOA (US)—ASA, FSA • Practice Areas: All covered • Choose specialty track after obtaining ASA • Self-study or university curriculum to master actuarial concepts • Advance through series of exams to earn credential • Complete/attend certain modules/courses https://www.soa.org/education/general-info/default/ CAS (USA)– ACAS, FCAS • Practice Area: Property & Casualty • Self-study or university curriculum to master concepts • University and exam pathways • Advance through a series of exams to earn credential • Complete/attend certain modules/courses https://www.casact.org/admissions/process/ 6 Becoming an Actuary – 4 Primary Intl.
    [Show full text]
  • Exam FM: Financial Mathematics
    Welcome! The Actuarial Science program prepares student for careers as actuaries. It helps them learn material that is included in processional examinations administered by the Society of Actuaries and Casualty Actuary Society, which actuarial students must pass in order to achieve professional status. Thank you for your interest in our Actuarial Science Program at the University of Iowa. The Actuarial Science program prepares students for careers as actuaries. It helps them learn material that is included in professional examinations administered by the Society of Actuaries, which actuarial students must pass in order to achieve professional status. In addition to actuarial science courses, students can take courses in preparation for business aspects of the actuarial profession such as accounting, law, finance, insurance, and economics. The Society of Actuaries (SOA) has recognized University of Iowa’s actuarial science program as a Center of Actuarial Excellence (CAE). There are eight criteria for the designation, including curriculum, faculty composition, graduate quality, connection to industry, and research/scholarship. We are a small department in a large University and graduate between 20-15 students each year. We do have SELECTIVE admission due to the difficulty of the professional examinations. Students interested in becoming actuaries should declare an Interest in Actuarial Science as their major when they ENTER the university. Ordinarily, students apply for admission to the Actuarial Science major in the fall semester of their sophomore year, after they have taken Math:2850 (22M:028) Calculus III or MATH:3770 (22M:055) Fundamental Properties of Spaces and Functions I and STAT:3100 (22S:130) Introduction to Mathematical Statistics I.
    [Show full text]
  • Sweden Restricts Gatherings to Eight People As Cases Reach Record Highs
    NEWS BMJ: first published as 10.1136/bmj.m4508 on 19 November 2020. Downloaded from Stockholm, Sweden Cite this as: BMJ 2020;371:m4508 Sweden restricts gatherings to eight people as cases reach record http://dx.doi.org/10.1136/bmj.m4508 highs Published: 19 November 2020 Marta Paterlini Sweden’s population of 10 million will be subject to tougher restrictions from 24 November after the prime minister announced that gatherings will be limited to eight people for four weeks, down from events involving up to 300 people, which have been permitted to date. “This is the new norm for the entire society, because it’s going to get worse,” Stefan Löfven said, adding that a total lockdown was not an option. The highly debated Swedish soft approach to controlling the coronavirus pandemic, based on recommendations and voluntary behaviour of citizens, continues to be challenged by a surge in new infections, hospitalisations, and deaths. The resurgence of the disease hit Sweden weeks later than much of continental Europe, but cases have been on the rise since the start of November. On 13 November, the last day for which national data are available, Sweden reported a daily record of 5990 cases, bringing its overall total to 177 355 cases and 6164 deaths since the start of the pandemic. Commenting on the current situation in Europe, Anders Tegnell, state epidemiologist at the Swedish Public Health Agency and face of the country’s soft strategy, said that the large increase in cases seen in many countries in early autumn was starting to level off.
    [Show full text]
  • UMBC Alumnae Racing to Develop Coronavirus Vaccine
    Newsletter SPRING 2020 To our UMBC/Meyerhoff families: We hope you and your families are all doing well during this strange and stressful time of Covid- 19. Although the world has changed quickly with so many things shut down and many of us sheltering at home, we hope this newsletter will represent a ray of sunshine during a dark and difficult time. Please enjoy this positive representation of our student and alumni community. MPA Board UMBC Alumnae Racing to Develop Coronavirus Vaccine Kizzmekia Corbett ’08, M16, biological sciences, says it feels like she’s “living in a constant adrenaline rush.” Maybe that’s because she and her team at the Vaccine Research Center at the National Insti- tute of Allergy and Infectious Diseases have been working around the clock for weeks. They’re racing to develop a vaccine for the coronavirus faster than it can race across the globe. “To be living in this moment where I have the opportunity to work on something that has imminent global importance…it’s just a surre- al moment for me,” Corbett says. Despite it feeling surreal, the advances Corbett and her team are making are very real, and they’re setting records. “We are making better progress than I could have ever hoped for,” she says. After three months of studies in test tubes and in animals, the vaccine her team developed is about to enter a phase I clinical trial, a crucial hur- dle on the way to FDA approval. Read the complete article about Kizzmekia and her team’s efforts to develop a Covid-19 vaccine in the latest UMBC magazine at https:// Kizzmekia Corbett, NIH magazine.umbc.edu/umbc-alumnae-racing-to-develop- coronavirus-vaccine/.
    [Show full text]
  • Swedish Response to COVID-19
    China CDC Weekly Policy Notes Swedish Response to COVID-19 Johan Carlson1; Anders Tegnell1,# Editorial Among the global responses to expectancies of 81.3 years for males and 84.7 years for COVID-19, Sweden’s response has received both females; low maternal and child mortality rates; and a demographic distribution with 20% of the population praise and criticism for the implementation of >65 years (1). Sweden has highly-subsidized universal certain measures. This paper, provided by Public healthcare coverage. Management of the healthcare Health Agency Sweden’s Director General Johan system, including communicable disease response, is Carlson and State Epidemiologist Anders Tegnell, decentralized to 21 regions. The Public Health Agency describes the main goals of Sweden’s public health coordinates communicable disease response nationally response: minimizing transmission, mortality, and and has a broad mandate for public health, including morbidity; minimizing other negative health prevention and control of non-communicable diseases effects and externalities of the pandemic; and and support for mental health and health equity. safeguarding essential services in the society. Government expert agencies in Sweden have strong While some of the stances or strategies described mandates at the national level to inform policy; trust may differ from China CDC’s recommendations among the general population in government or other measures adopted in China, China CDC institutions and the healthcare system is fairly high (2). Weekly seeks to act as a platform for global voices to disseminate and discuss a variety of viewpoints THE COVID-19 OUTBREAK to achieve an improved, mutual understanding of our counterparts. IN SWEDEN Sweden had a massive introduction of the virus in February 2020, particularly in Stockholm, and not INTRODUCTION only from the Alps.
    [Show full text]
  • Actuarial Studies Within the Biometry and Statistics and Statistical Science Majors
    Actuarial Studies within the Biometry and Statistics and Statistical Science majors An actuary is a business professional who analyzes the financial consequences of risk. Actuaries use mathematics, statistics and financial theory to study uncertain future events, especially those of concern to insurance and pension programs. They evaluate the likelihood of those events, design creative ways to reduce the likelihood and decrease the impact of adverse events that actually do occur. To be more specific, actuaries improve financial decision making by developing models to evaluate the current financial implications of uncertain future events. Actuaries are an important part of the management team of the companies that employ them. Their work requires a combination of strong analytical skills, business knowledge and understanding of human behavior to design and manage programs that control risk. No matter the source, actuary is consistently rated as one of the best jobs in America. US News and World Report, the Jobs Rated Almanac, CNN Money, and others all agree: few other occupations offer the combination of benefits that an actuarial career can offer. In almost every job satisfaction category, such as work environment, employment outlook, job security, growth opportunity, and salary (especially starting salary), a career as an actuary is hard to beat. Required courses for the Biometry and Statistics and Statistical Science majors Calculus I and II: MATH 1110 & 1120 Multivariable Calculus and Linear Algebra: MATH 2210 & 2220 or 2230 & 2240
    [Show full text]
  • Comparing the Scope and Efficacy of COVID-19 Response Strategies In
    International Journal of Environmental Research and Public Health Article Comparing the Scope and Efficacy of COVID-19 Response Strategies in 16 Countries: An Overview Liudmila Rozanova 1,2,*, Alexander Temerev 1 and Antoine Flahault 1,2,3,4 1 Institute of Global Health, University of Geneva, 1202 Geneva, Switzerland; [email protected] (A.T.); antoine.fl[email protected] (A.F.) 2 Global Studies Institute, University of Geneva, 1205 Geneva, Switzerland 3 Swiss School of Public Health (SSPH+), 8001 Zurich, Switzerland 4 Hôpitaux Universitaires de Genève (HUG), 1205 Geneva, Switzerland * Correspondence: [email protected] Received: 17 October 2020; Accepted: 14 December 2020; Published: 16 December 2020 Abstract: This article synthesizes the results of case studies on the development of the coronavirus disease 2019 (COVID-19) pandemic and control measures by governments in 16 countries. When this work was conducted, only 6 months had passed since the pandemic began, and only 4 months since the first events were recognized outside of China. It was too early to draw firm conclusions about the effectiveness of measures in each of the selected countries; however, the authors present some efforts to identify and classify response and containment measures, country-by-country, for future comparison and analysis. There is a significant variety of policy tools and response measures employed in different countries, and while it is still hard to directly compare the different approaches based on their efficacy, it will definitely provide many inputs for the future data analysis efforts. Keywords: COVID-19; coronavirus; case studies; comparison; public health; epidemic response 1. Introduction In some European, North American, and South East Asian countries and territories, the first wave of the coronavirus disease 2019 (COVID-19) epidemic was showing a decline in late June 2020 when it was raging in other parts of the world, particularly in the United States, Latin America, South Africa, Saudi Arabia, Iran, India, Pakistan, Bangladesh, and Indonesia.
    [Show full text]
  • COVID-19Predict – Predicting Pandemic Trends
    medRxiv preprint doi: https://doi.org/10.1101/2020.09.09.20191593; this version posted September 11, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Title: COVID-19Predict – Predicting Pandemic Trends. Authors Jürgen Bosch1,2, Austin Wilson3, Karthik O’Neil4, Peter A. Zimmerman5,6 Institutional Affiliations 1 Division of Pediatric Pulmonology and Allergy/Immunology, Case Western Reserve University, Cleveland, OH, United States 2InterRayBio, LLC, Baltimore, MD, United States 3 Department of Computer Science, Case Western Reserve University, Cleveland, OH, United States 4 Andrews Osborne Academy (AOA), Willoughby, OH, United States 5 The Center for Global Health and Diseases, Pathology Department, Case Western Reserve University, Cleveland, OH, United States 6 Masters of Public Health Program, Department of Population Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, United States 1 NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2020.09.09.20191593; this version posted September 11, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Abstract Background Given the global public health importance of the COVID-19 pandemic, data comparisons that predict on-going infection and mortality trends across national, state and county-level administrative jurisdictions are vitally important.
    [Show full text]
  • March 11, 2021
    Sector Email 3.11.2021 Subject header: Updates on COVID-19 from Public Health - Seattle & King County (PHSKC) Schools Dear school partners, March is Women’s History Month and this year we are grateful to some of the women who are making history by changing the course of the COVID-19 pandemic. Have you learned about Kizzmekia Corbett, an African American Immunologist who co-led the development of the Moderna COVID-19 vaccine. This month, we celebrate Dr. Corbett and thousands of her colleagues in healthcare, research and public health as women who are making history. Reminder: please review the King County Schools COVID-19 Response Toolkit, related resources, and training videos. ---------- This week’s Public Health—Seattle & King County (PHSKC) Schools and Child Care Task Force sector email includes the following topics: 1. Key indicators of COVID-19 activity 2. Vaccine Updates a. Educators, school staff and child care workers now eligible for COVID-19 vaccine b. How school and child care staff can access vaccines c. Getting Vaccinated Resources d. Signs and Symptoms Following Vaccination 3. COVID Community Vaccination Event Planning Workbooks 4. Special Enrollment for Washington Health Care 5. Updated Mask Posters 6. Events a. Public Health’s upcoming trainings and community discussions on COVID-19 b. COVID-19 Vaccination Webinar and Q&A c. COVID-19 Vaccine Distribution Webinar and Q&A d. Oromo Session – COVID-19 and Vaccinations e. Somali Session – COVID-19 and Vaccinations 7. Updated Guidance from the CDC – When You’ve Been Fully Vaccinated 8. School and District Town Hall Meetings 9.
    [Show full text]
  • Guide to SOA Written Exams
    Guide to SOA Written Exams GUIDE TO SOA EXAMS Updated November 2020 Guide to SOA Exams Table of Contents 1. INTRODUCTION ............................................................................................. 1 1.1. Purpose of this Document ................................................................................................... 1 1.2. Education Principles ............................................................................................................ 1 1.2.1. Assessment Methods Principle .......................................................................... 2 1.2.2. International Organizations Principle ................................................................. 3 1.3. Organizational Structure of Education ............................................................................... 3 2. OVERVIEW AND DEFINITIONS ..................................................................... 3 2.1. Designations/Credentials .................................................................................................... 3 2.1.1. Meaning of the ASA ........................................................................................... 3 2.1.2. Meaning of the FSA ........................................................................................... 4 2.1.3. Meaning of the CERA ........................................................................................ 4 2.2. Component Groupings ........................................................................................................ 4 3.
    [Show full text]
  • Schooling During COVID-19
    Schooling during COVID-19 Recommendations from the European Technical Advisory Group for schooling during COVID-19 March 2021 ABSTRACT These recommendations from the Technical Advisory Group (TAG) on Schooling during the COVID-19 pandemic of the WHO Regional Office for Europe represent the work of the TAG between October 2020 and March 2021. The recommendations were considered at a WHO ministerial meeting on 8 December 2020, after which they were reviewed and updated. The recommendations are endorsed by the TAG to represent the best available evidence and expert advice on safe schooling. Keywords CHILD SCHOOL COVID-19 SARS-COV-2 SCHOOL TEACHER INFECTION CONTROL WHO/EURO:2021-2151-41906-57497 © World Health Organization 2021 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no sugges- tion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation.
    [Show full text]
  • Actuary Brochure
    Our actuarial professionals play a critical role in society and enjoy benefits available to members of the SOA: • Advanced actuarial and risk management education and knowledge-sharing opportunities • Extensive professional development/ continuing education programs • Access to a variety of publications and the most research activity on a wide range of current pertinent topics that will help in their roles as actuarial professionals • Social and professional networking communities • Members-only pricing on widest array Educating actuaries. Advancing a profession. Impacting society. of extensive professional development opportunities • The ability to take part in professional interest groups—20 from which to choose Take a closer look at the SOA at soa.org soa.org I asia.soa.org I [email protected] I +1 847.706.3500 475 North Martingale Road, Suite 600 I Schaumburg, Illinois 60173, USA From the current state of public pensions to the changing role of big data in business, we see the potential impact of risk—and the growing need to better mitigate it—around the world. That’s why we’re here. We are the Society of Actuaries (SOA), the largest global professional actuarial organization in the world. Every day, our more than 26,000 members in 78 countries take a closer look at the bigger picture of risk. Asking the questions that dig deeper. Mining data for solutions that Risk is everywhere. have a positive impact on business and society. A pioneering organization with unmatched research and education resources, we foster innovative thinking on real-world challenges. Together, we cultivate the well-rounded professionals trusted to bring better decisions into focus.
    [Show full text]